NCT07455019 2026-03-06
A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06015035 2023-08-29
Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer
Tang-Du Hospital
Phase 2 Completed
NCT05996484 2023-08-21
Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma
Nanfang Hospital, Southern Medical University
Phase 2 Not yet recruiting
NCT05866510 2023-05-19
Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer
Peking University
Phase 2 Unknown
NCT05303740 2022-03-31
Anlotinib Retrospective Study for Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University
Completed
NCT04966611 2021-07-19
Anlotinib for Esophageal Cancer (AFEC)
Anyang Tumor Hospital
Unknown